In line with these observations, patients with HLA class I antigen-deficient uveal melanoma had a better prognosis compared with their HLA class I antigen-proficient counterparts (Blom et al, 1997; Jager et al, 2002). The gene discussed is MICA; the disease is uveal melanoma.